AKBA Historical Earnings image   This AKBA historical earnings page last updated 8/8/2022
AKBA Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.13B
Q1 20225/9/20220.06B
Q4 20213/1/20220.06B
Q3 202111/4/20210.05B
Q2 20218/5/20210.05B
Q1 20215/10/20210.05B
Q4 20202/25/20210.06B
Q3 202011/5/20200.06B
Q2 20208/10/20200.09B
Q1 20205/5/20200.09B
Q4 20193/10/20200.07B
Q3 201911/12/20190.09B
Q2 20198/8/20190.10B
Q1 20195/9/20190.07B
Q4 20183/18/201959.85M
Q3 201811/8/201853.17M
Q2 20188/8/201848.79M
Q1 20185/9/201845.93M
Q4 20173/12/201887.32M
Q3 201711/8/201741.28M
Q2 20178/8/201728.52M
Q1 20175/9/201720.86M
Q4 20163/6/20171.53M
Q3 201611/9/2016NA
Q2 20168/9/2016NA
Q1 20165/5/2016NA
Q4 20153/14/2016NA
Q3 201511/9/2015NA
Q2 20158/11/2015NA
Q1 20155/11/2015NA
Q4 20143/4/2015NA
Q3 201411/10/2014NA
Q2 20148/11/2014NA
Q1 20145/12/2014NA
AKBA Historical Earnings EPS
PeriodHistorical Earnings DateAdj. EPS
Q2 20228/4/20220.230
Q1 20225/9/2022-0.350
Q4 20213/1/2022-0.400
Q3 202111/4/2021-0.340
Q2 20218/5/2021-0.510
Q1 20215/10/2021-0.450
Q4 20202/25/2021-0.600
Q3 202011/5/2020-0.420
Q2 20208/10/2020-0.440
Q1 20205/5/2020-0.470
Q4 20193/10/2020-0.790
Q3 201911/12/2019-0.460
Q2 20198/8/2019-0.250
Q1 20195/9/2019-0.44
Q4 20183/18/2019-0.76
Q3 201811/8/2018-0.46
Q2 20188/8/2018-0.6
Q1 20185/9/2018-0.48
Q4 20173/12/20180.25
Q3 201711/8/2017-0.49
Q2 20178/8/2017-0.53
Q1 20175/9/2017-1.15
Q4 20163/6/2017-0.99
Q3 201611/9/2016-0.96
Q2 20168/9/2016-0.95
Q1 20165/5/2016-0.7
Q4 20153/14/2016-0.66
Q3 201511/9/2015-0.68
Q2 20158/11/2015-0.4
Q1 20155/11/2015-0.53
Q4 20143/4/2015-0.52
Q3 201411/10/2014-0.47
Q2 20148/11/2014-0.39
Q1 20145/12/2014-43.37
Quotes delayed 20 minutes

Email EnvelopeFree AKBA Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Akebia Therapeutics (AKBA) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

AKRO Historical Earnings
AKUS Historical Earnings
AKYA Historical Earnings
ALBO Historical Earnings
ALDX Historical Earnings
ALEC Historical Earnings
ALGN Historical Earnings
ALGS Historical Earnings
ALHC Historical Earnings
ALIM Historical Earnings
What was the record high AKBA historical earnings result?
In terms of earnings or revenue, what is the best AKBA historical earnings result that Akebia Therapeutics has ever posted, and when?

✔️Accepted answer: Within our data set, the highest AKBA historical earnings result was set in Q4 2017, when Akebia Therapeutics posted results of 0.25/share. The most successful revenue quarter within our data set was Q2 2022 when Akebia Therapeutics reported revenue of 0.13B.

What was the lowest Akebia Therapeutics historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest AKBA has reported, and when?

✔️Accepted answer: Within our data set, the lowest AKBA historical earnings result was set in Q1 2014, when Akebia Therapeutics posted results of -43.37/share. The smallest revenue quarter within our data set was Q3 2016 when Akebia Therapeutics reported revenue of NA.

On this page we presented the AKBA historical earnings date information for Akebia Therapeutics. Reviewing that AKBA Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2017, when AKBA posted adjusted EPS of 0.25/share. Meanwhile the lowest AKBA historical earnings result was in Q1 2014, when AKBA posted adjusted EPS of -43.37/share. Moving to Akebia Therapeuticss historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when AKBA reported 0.13B in revenue, while the smallest revenue quarter was Q3 2016 when AKBA reported NA in revenue.

For self directed investors doing their due diligence on AKBA or any other given stock, their research can benefit from looking into all of the Akebia Therapeutics historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Akebia Therapeutics historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for AKBA. Thanks for visiting, and the next time you need to research AKBA historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: APRN Average Annual Return, GROM Videos, WWE Insider Buying.

 

AKBA Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.